Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| BT1-H52H4 | Human | Human BTN3A1 / CD277 Protein, His Tag, active dimer (MALS verified) |
|
|
|
| BT1-H82E4 | Human | Biotinylated Human BTN3A1 / CD277 Protein, His,Avitag™ |  |
|
|
| BT1-C52H3 | Cynomolgus | Cynomolgus BTN3A1 / CD277 Protein, His Tag |  |
|
|
| BT1-H82F7 | Human | Biotinylated Human BTN3A1 / CD277 Protein, Fc,Avitag™ |  |
|
|
| BT1-H5255 | Human | Human BTN3A1 / CD277 Protein, Fc Tag (MALS verified) |  |
|
Immobilized Anti-BTN3A123 Antibody, Mouse IgG1 at 1 μg/mL (100 μL/well) can bind Biotinylated Human BTN3A1 Protein, His,Avitag (Cat. No. BT1-H82E4) with a linear range of 0.1-4 ng/mL (QC tested).
The purity of Human BTN3A1 Protein, His Tag (Cat. No. BT1-H52H4) is more than 85% and the molecular weight of this protein is around 65-80 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| ICT-01(Imcheck Therapeutics) | ICT-01 | Phase 2 Clinical | ImCheck Therapeutics SAS | Solid tumours; Hematologic Neoplasms; Neoplasms; Lymphoma | Details |
This web search service is supported by Google Inc.
A-Z
